Screener
Charles River Laboratories CRL Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $192,025 | $213,770 |
| Trade receivables and contract assets, net of allowances for credit losses of $8,715 and $10,463, respectively | 711,755 | 708,856 |
| Inventories | 346,260 | 299,103 |
| Prepaid assets | 100,409 | 96,108 |
| Other current assets | 178,657 | 129,212 |
| Total current assets | 1,529,106 | 1,447,049 |
| Property, plant and equipment, net | 1,494,914 | 1,655,219 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's inventories?
- Charles River Laboratories (CRL) reported inventories of $346.26M in Q2 2026.
- How has Charles River Laboratories's inventories changed year-over-year?
- Charles River Laboratories's inventories increased by 23.9% year-over-year, from $279.55M to $346.26M.
- What is the long-term trend for Charles River Laboratories's inventories?
- Over 5 years (2020 to 2025), Charles River Laboratories's inventories has grown at a 10.0% compound annual growth rate (CAGR), from $185.7M to $299.1M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Charles River Laboratories's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude